When Cancer Immunotherapy Silences the Thyroid Twice: A Rare One-Two Endocrine Blow
A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...
A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...
A Japanese retrospective cohort study of 188 patients found that the prevalence of neutropenia did not differ significantly across the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine